Editorial Board Disclosure Policy
(Last updated July 2024)
All editors responsible for recommending or making publication decisions are requested to disclose on an annual basis any potential conflict of interest, including current or recent financial relationships with any commercial entity whose products or services may be contained in the journal content.
The following competing interests were disclosed:
Luca Persani (Editor-in-Chief) – Professor Persani receives consulting fees from Merck, Sandoz, Recordati Rare Diseases and Pfizer.
Saba P Balasubramanian – Professor Balasubramanian has received research grants from the NIHR and charities in UK relating to research in thyroid nodules and cancer.
Camille Buffet – Dr Buffet has consulted for Lilly, and has received lecture fees from IBSA, and Merck. She has received travel expenses and conference registration fees from IPSEN. She is also on the board of the French Endocrine Society.
Roderick Clifton-Bligh – Dr Clifton-Bligh has received funding from NHMRC. He has received speaking honoraria from: EISAI, AMGEN, IPSEN, KYOWA KIRIN.He is on the following advisory boards: AMGEN, EISAI, IPSEN, KYOWA KIRIN. He acts as an Associate Editor for Endocrine Reviews and is an Editorial Board Member of Journal of Endocrinology and Metabolism.
Marco Medici – Dr Medici has collaborated with and received a research grant from Ace pharmaceuticals for a LT4/LT3 combination therapy trial. He is on the Scientific Advisory Board for Prolevi Bio. Clinical trial site Graves’ orbitopathy IGF1-receptor antibody (Viridian Therapeutics). Consultancy for Goodlife Pharma. He serves on the Editorial Board for Thyroid and Thyroid Research.
Jens Mittag – Professor Mittag has received research grants from the German Research Council (DFG).
Romana Netea-Maier – Professor Netea-Maier has represented her institution as part of advisory boards and has given presentations or attended conferences sponsored by EISAI and Lilly. Her insitiution has received remuneration for her services within the lawfully permitted limits. She has received through her institution independent grants for investigator-initiated studies as well as travel expenses from EISAI.
Marek Niedziela – Professor Niedziela has received lecture fees from Termedia, and Astra Zeneca. His he involved with the following peer-reviewed publications: Thyroid Research (Editorial Board Member), Frontiers in Endocrinology (Review Editor for Pediatric Endocrinology), Frontiers in Pediatrics (Review Editor for Pediatric Endocrinology), Frontiers in Molecular Neuroscience (Review Editor for Brain Disease Mechanisms), Frontiers in Endocrinology (Guest Associate Editor for Pediatric Endocrinology), Frontiers in Pediatrics (Guest Associate Editor). for Pediatric Endocrinology), Pediatric Endocrinology Diabetes and Metabolism (Editorial Board) ETA Guidelines and Publications Board 2020-2023
Simon H Pearce – Professor Pearce consults on behalf of Newcastle University for Apitope/Worg, IBSA, Immunovant/ Roivant (fees accumulate to university). He is also on the Editorial Board for Thyroid Research.
Efisio Puxeddu – Professor Puxeddu has recieved honoraria as a consultant from EISAI S.R.L. He has also received honoraria for the participation to seminars and the preparation of case reports from Ely Lilly Italia S.P.A.
Patrice Rodien – Dr Rodien has received exceptional honoraria from pharmaceutical firms for acting on expert boards.
Iwao Sugitani – Professor Sugitani has received research grants from: Bayer, Eisai, Taiho, Kyowa-Kirin. He serves on the following advisory boards: Eli Lilly, Novartis, Ono. He has also received honoraria for lectures from: Eli Lilly, Novartis, Asuka, Medtronic, Eisai, Bayer, Johnson & Johnson. He serves on the editorial board for Thyroid Science (Official Journal of the Japan Thyroid Association).
Fernanda Vaisman – Dr Vaisman works for the Instituto Nacional do Cancer (INCA), Rio de janeiro, Brazil. She has received speaking fees from Sanofy-Genzyme, Ipsen, Merck, Lilly, United health, Exelisis. She is the Principal Investigator in clinical trials sponsored by Lilly, astraZeneca, Exelisis, Novartis. She has received travel expenses from Merck, lilly and Sanofi-genzyme. She serves on the Editorial Board for Endocrine and Archives of Endocrinology and Metabolism. She is on the Board of Directors of the Latin American Thyroid Society and of the Thyroid department of the Brazilian Socienty of Endocrinilogy and Metabolism
The following editors reported no competing interests:
- Iñigo Landa
- Mingzhao Xing
Bioscientifica staff and freelancers working on the journal reported no conflicts of interest. Article authors' declarations are stated in each journal article. Referees must disclose any competing interests before agreeing to review any submission. For more information on the journal’s ethical policy, please read the ethical guidelines.
This policy follows the recommendations of the International Committee of Medical Journals Editors (ICMJE) and the Committee on Publication Ethics (COPE).
